Bottles of Xanax – one of the most widely-prescribed medications for anxiety – have been recalled after failing a quality-control test, according to the Food and Drug Administration.
Viatris, Inc., a Pennsylvania-based pharmaceutical firm, in March initiated a voluntary recall of its 60-tablet bottles of Xanax, citing “failed dissolution specifications,” food safety regulators said.
That means a drug has failed a quality control test, implying the Xanax does not deliver the correct dosage over time and is not being properly absorbed.
Last week, the FDA classified it as a Class II recall, meaning use of the product may cause “temporary or medically reversible adverse health consequences.”
Read Full Article Here
